3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
10
Myelodysplastic Syndromes
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia
6
Hodgkin Disease
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Graft vs Host Disease
4
Myeloproliferative Disorders
3
Myelodysplastic-Myeloproliferative Diseases
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Blast Crisis
3
Anemia, Refractory, with Excess of Blasts
3
Waldenstrom Macroglobulinemia
2
Multiple Myeloma
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Prolymphocytic
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Biphenotypic, Acute
2
Hematologic Neoplasms
2
Congenital Abnormalities
2
Burkitt Lymphoma
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
beta-Thalassemia
1
Interventions
Rifaximin
1
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Paraproteinemias
×
Mycophenolic Acid
×
30 days
×
Clear all
No trials found.